Zahravi Pharmacutical Co (XTEH:DZAH1) Current Accrued Expense : IRR0.00 Mil (As of . 20)

View and export this data going back to 1990. Start your Free Trial

What is Zahravi Pharmacutical Co Current Accrued Expense?

Zahravi Pharmacutical Co's Current Accrued Expense for the quarter that ended in . 20 was IRR0.00 Mil.

Zahravi Pharmacutical Co Current Accrued Expense Historical Data

The historical data trend for Zahravi Pharmacutical Co's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zahravi Pharmacutical Co Current Accrued Expense Chart

Zahravi Pharmacutical Co Annual Data

Trend

Current Accrued Expense

Zahravi Pharmacutical Co Semi-Annual Data

Current Accrued Expense

Zahravi Pharmacutical Co Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

Zahravi Pharmacutical Co Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Zahravi Pharmacutical Co's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Zahravi Pharmacutical Co (XTEH:DZAH1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zahravi Pharmacutical Co (XTEH:DZAH1) » Definitions » Current Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

18th km of Karaj Special Road, Darupakhsh Street, Darupakhsh Factories, Entrance No. 2, No. 23, Tehran, IRN

Website

http://www.zahravi.com

Zahravi Pharmacutical Co is engaged in the pharmaceutical sector. It produces various tablets, capsules, injections, and soft gel capsules. Some of its products are Cograft, Iminoral, Clexaparin, Roaccutane, and others.

Zahravi Pharmacutical Co (XTEH:DZAH1) Headlines

No Headlines